Probable emergence of symptoms of trichotillomania by atomoxetine: a case report
Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood. Atomoxetine is the first nonpsychostimulant agent approved by the Food and Drug Administration for the treatment of ADHD. Trichotillomania (TTM) is an obsessive-compulsive and related disorder chara...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2019-04-01
|
| Series: | Psychiatry and Clinical Psychopharmacology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/24750573.2018.1439601 |